InnoCare Pharma News

InnoCare Pharma: Monthly securities change report.

Jul 5 00:00

Announcement of the resolutions of the 2024 Shareholders' Annual Meeting of Innocare Pharmaceutical Co., Ltd.

Jun 28 00:00

Innocare Pharmaceutical Co., Ltd. Announcement on using idle self-owned funds for cash management.

Jun 26 00:00

Announcement of innocare pharmaceutical co., LTD. on the cancellation of some unallocated restricted stocks.

Jun 26 00:00

Innocare Pharmaceuticals voluntarily disclosed an announcement regarding the acceptance by the National Medical Products Administration of the biological product license for tafasitamab and lenalidomide in the treatment of relapsed or refractory diffuse large B-cell lymphoma.

Jun 21 00:00

InnoCare Pharma: Monthly securities change report.

Jun 5 00:00

InnoCare Pharma: Monthly statement of changes in securities

May 7 00:00

InnoCare Pharma: Date of Board Meeting

Apr 30 00:00

Meeting materials of the 2024 Annual General Meeting of Shareholders of Nuochengjianhua Pharmaceutical Co., Ltd.

Apr 27 00:00

InnoCare Pharma: 2023 Annual Report

Apr 27 00:00

Notice of Nuochengjianhua Pharmaceutical Co., Ltd. on holding the 2024 Annual General Meeting of Shareholders

Apr 27 00:00

Hong Kong Stock Announcement: Monthly Report on Changes in Securities

Apr 4 00:00

Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on amending the “Articles of Association”

Mar 29 00:00

Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on authorizing companies and wholly-owned subsidiaries to provide guarantees for holding subsidiaries

Mar 29 00:00

The most recent financial statements of the guarantors

Mar 29 00:00

Hong Kong Stock Announcement: Date of Board Meeting

Mar 16 00:00

Hong Kong Stock Announcement: Monthly Report on Changes in Securities

Mar 5 00:00

Hong Kong Stock Announcements: Notification Letter to Registered Shareholders - Arrangements for Electronic Publishing of Corporate Communications and Reply Form

Mar 2 00:00

Hong Kong Stock Announcements: Notification Letter to Non-registered Shareholders - Arrangements for Electronic Publishing of Corporate Communications and Reply Form

Mar 2 00:00

Hong Kong Stock Announcement: Next Day Disclosure Report

Feb 24 00:00